This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Workman, P., Walton, M., Powis, G. et al. DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs?. Br J Cancer 60, 800–803 (1989). https://doi.org/10.1038/bjc.1989.364
Issue Date:
DOI: https://doi.org/10.1038/bjc.1989.364
This article is cited by
-
Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX‐1
Lipids (1995)
-
The experimental development of bioreductive drugs and their role in cancer therapy
Cancer and Metastasis Reviews (1993)
-
DT-diaphorase in activation and detoxification of quinones
Cancer and Metastasis Reviews (1993)
-
The role of NAD(P)H: quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells
Cancer Chemotherapy and Pharmacology (1992)
-
Porfiromycin disposition in oxygen-modulated P388 cells
Cancer Chemotherapy and Pharmacology (1990)